Document:

Exhibit  10.115

 

THIS WARRANT AND THE EQUITY INTERESTS
THAT MAY BE PURCHASED HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE SECURITIES
LAWS OF ANY STATE, AND MAY NOT BE SOLD OR TRANSFERRED, OR OFFERED FOR SALE OR TRANSFER, EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
THEREUNDER OR PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS THEREOF.

 

TWINLAB CONSOLIDATED HOLDINGS, INC.

 

	No. 2016 - 2	January, 28 2016

 

Warrant

 

This Warrant (the "Warrant")
certifies that, for value received, Great Harbor Capital, LLC, and its permitted transferees, successors and assigns (the "Holder"),
is entitled to purchase from TWINLAB CONSOLIDATED HOLDINGS, INC., a Nevada corporation (the "Company"), One Million
One Hundred Thirty Six Thousand Three Hundred Sixty Three (1,136,363) shares of common stock of the Company (subject to any adjustments
pursuant to Section 3.3) issuable upon the full exercise of this Warrant at the purchase price of $0.01 per share (the "Exercise
Price"), at any time prior to 5:00 P.M. Eastern Time on February 28, 2022 (the "Expiration Date").

 

ARTICLE I

 

DEFINITIONS

 

SECTION 1.1  Definitions.
As used in this Warrant, the following terms shall have the following meanings:

 

"Applicable Law"
means all provisions of laws, statutes, ordinances, rules, regulations, permits, certificates or orders of any Governmental Authority
applicable to the Person in question or any of its assets or property, and all judgments, injunctions, orders and decrees of all
courts and arbitrators in proceedings or actions in which the Person in question is a party or by which any of its assets or properties
are bound.

 

"Assignment Form"
shall mean the assignment form attached as Annex 2 hereto.

 

"Affiliate"
or "Affiliated" means, as applied to (i) any Person, directly or indirectly, in which such Person holds, beneficially
or of record, ten percent (10%) or more of the equity of voting securities; (ii) any Person that holds, of record or beneficially,
ten percent (10%) or more of the equity or voting securities of such Person; (iii) any director, officer, partner or individual
holding a similar position in respect of such Person; (iv) as to any natural Person, any Person related by blood, marriage or adoption
and any Person owned by such Persons, including any spouse, parent, grandparent, aunt, uncle, child, grandchild, sibling, cousin
or in-law of such Person; or (v) any other Person directly or indirectly controlling, controlled by, or under common control with,
that Person. For the purposes of this definition, "control" (including, with correlative meanings, the terms "controlling",
"controlled by" and "under common control with"), as applied to any Person, means the possession, directly
or indirectly, of the power to direct or cause the direction of the management and policies of that Person, whether through the
ownership of voting securities or by contract or otherwise.

 

    	 	 	 

     

    

  

"Business Day"
means any day excluding Saturday, Sunday and any day which is a legal holiday under the laws of the State of New York or is a day
on which banking institutions located in such state are authorized or required by law or other governmental action to close.

 

"Company"
shall have the meaning set forth in the Preamble.

 

"Current Holder’s
Equity Interest" means One Million One Hundred Thirty Six Thousand Three Hundred Sixty Three (1,136,363) shares of common
stock of the Company issuable upon the full exercise of this Warrant, minus any Equity Interest previously issued pursuant to the
exercise of this Warrant.

 

"Delivery Date"
shall have the meaning given to such term in Section 3.2.

 

"Equity Interest"
shall mean the interest of (i) a shareholder in a corporation, (ii) a partner (whether general or limited) in a partnership (whether
general, limited or limited liability), (iii) a member in a limited liability company, or (iv) any other Person having any other
form of equity security or ownership interest in any Person.

 

"Exchange Act"
shall mean the Securities Exchange Act of 1934, as amended from time to time, and any successor statute.

 

"Exchange Form"
shall mean the exchange form attached as Annex 3 hereto.

 

"Executive Officer"
shall mean, with respect to the Company, its Chief Executive Officer, President, Chief Financial Officer or Chief Operating Officer.

 

"Exercise Form"
shall mean the exercise form attached as Annex 1 hereto.

 

"Exercise Price"
shall have the meaning set forth in the Preamble.

 

"Expiration Date"
shall have the meaning set forth in the Preamble.

 

"GAAP" shall
mean generally accepted accounting principles in the United States as of the relevant date in question, consistently applied.

 

"Governmental Authority"
means any arbitrator or any governmental authority, agency, department, commission, bureau, board, instrumentality, court or quasi-governmental
authority having jurisdiction or supervisory or regulatory authority over the Company.

 

"Holder"
shall have the meaning set forth in the Preamble.

 

"Holder's Equity
Interest" shall have the meaning given to such term in Section 3.3.

 

    	 	2	 

     

    

  

"Note" shall
mean an Unsecured Promissory Note dated January 28, 2016 in the original principal amount of $2,500,000 executed and delivered
by the Company by the Holder.

 

"Person"
shall mean any individual, corporation, partnership, limited liability company, trust, unincorporated organization, or any other
form of entity.

 

"Rights Agreement"
shall have the meaning given to such term in Section 4.1.

 

"Securities Act"
shall mean the Securities Act of 1933, as amended from time to time, and any successor statute.

 

"Subsidiary"
shall mean a corporation or other entity any of whose Equity Interests having ordinary voting power (other than Equity Interests
having such power only by reason of the happening of a contingency) to elect a majority of the directors of such corporation, or
other Persons performing similar functions for such entity, are owned, directly or indirectly, by such Person.

 

"Taxes"
means all taxes, charges, fees, levies or other assessments, however denominated and whether imposed by a taxing authority within
or without the United States, including all net income, gross income, gross receipts, sales, use, ad valorem, goods and services,
capital, transfer, franchise, profits, license, withholding, payroll, employment, employer health, excise, estimated, severance,
stamp, occupation, property or other taxes, custom duties, fees, assessments or charges of any kind whatsoever, together with any
interest and any penalties, additions to tax or additional amounts imposed by any taxing authority whether arising before, on or
after the date hereof.

 

"Warrant"
or "Warrants" shall mean this Warrant.

 

"Warrant Register"
shall have the meaning given to such term in Section 2.1.

 

SECTION 1.2  Interpretation.
Unless the context of this Warrant clearly requires otherwise, the masculine, feminine or neuter gender and the singular or plural
number shall be deemed to include the others whenever the context so requires. Accounting terms used but not otherwise defined
herein have the meanings given to them under GAAP. The terms "include," "includes" and "including"
shall be deemed to be followed by the phrase "without limitation." The words "hereof," "herein,"
"hereunder," and similar terms in this Warrant refer to this Warrant as a whole and not to any particular provision of
this Warrant. References to "Articles", "Sections," "Subsections," "Exhibits," "Preamble,"
"Annexes," and "Schedules" are to articles, sections, subsections, exhibits, preamble, annexes and schedules,
respectively, of this Warrant, unless otherwise specifically provided. References to "days" and "months" refer
to calendar days and calendar months unless otherwise expressly designated (i.e., business days or particular 30-day periods).
The captions contained herein are for convenience only and shall not control or affect the meaning or construction of any provision
of this Warrant. The term "dollars" or "$" means United States Dollars.

 

    	 	3	 

     

    

  

ARTICLE II

 

FORM; EXCHANGE FOR WARRANTS;
TRANSFER; TAXES

 

SECTION 2.1  Warrant
Register. Each Warrant issued, exchanged or transferred shall be registered in a warrant register (the "Warrant Register").
The Warrant Register shall set forth the number of each Warrant, the name and address of the holder thereof, and the Current Holder’s
Equity Interest for which the Warrant is then exercisable. The Warrant Register will be maintained by the Company and will be available
for inspection by the Holder at the principal office of the Company or such other location as the Company may designate to the
Holder in the manner set forth in Section 5.1 hereof. The Company shall be entitled to treat the Holder as the owner in
fact thereof for all purposes and shall not be bound to recognize any equitable or other claim to or interest in such Warrant on
the part of any other Person.

 

SECTION 2.2  Exchange
of Warrants for Warrants.

 

(a)         The
Holder may exchange this Warrant for another Warrant or Warrants of like kind and tenor representing in the aggregate the right
to purchase the same Current Holder’s Equity Interest which could be purchased pursuant to the Warrant being so exchanged.
In order to effect an exchange permitted by this Section 2.2, the Holder shall deliver to the Company such Warrant accompanied
by an Exchange Form in the form attached hereto as Annex 3 signed by the Holder thereof specifying the number and denominations
of Warrants to be issued in such exchange and the names in which such Warrants are to be issued. Within ten (10) Business Days
of receipt of such a request, the Company shall issue, register and deliver to the Holder thereof each Warrant to be issued in
such exchange.

 

(b)         Upon
receipt of evidence reasonably satisfactory to the Company (an affidavit of the Holder, including indemnification reasonably acceptable
to the Company) of the ownership and the loss, theft, destruction or mutilation of any Warrant or, in the case of any such mutilation,
upon surrender of such Warrant, the Company shall (at its expense) execute and deliver in lieu of such Warrant a new Warrant of
like kind and tenor representing the same rights represented by and dated the date of such lost, stolen, destroyed or mutilated
Warrant. Any such new Warrant shall constitute an original contractual obligation of the Company, whether or not the allegedly
lost, stolen, mutilated or destroyed Warrant shall be at any time enforceable by any Person.

 

(c)         The
Company shall pay all Taxes (other than any applicable income or similar Taxes payable by a Holder of a Warrant) attributable to
an exchange of a Warrant pursuant to this Section 2.2; provided, however, that the Company shall not be required
to pay any Tax which may be payable in respect of any transfer involved in the issuance of any Warrant in a name other than that
of the Holder of the Warrant being exchanged.

 

    	 	4	 

     

    

  

SECTION 2.3  Transfer
of Warrant.

 

(a)         Subject
to Section 2.3(c) hereof, each Warrant and the rights thereunder may be transferred by the Holder thereof, in whole or in
part, by delivering to the Company such Warrant accompanied by a properly completed Assignment Form in the form of Annex 2.
Within ten (10) Business Days of receipt of such Assignment Form the Company shall issue, register and deliver to the new Holder,
subject to Section 2.3(c) hereof a new Warrant or Warrants of like kind and tenor representing in the aggregate the right
to purchase the same Current Holder’s Equity Interest which could be purchased pursuant to the Warrant being transferred.
In all cases of transfer by an attorney, the original power of attorney, duly approved, or a copy thereof, duly certified, shall
be deposited and remain with the Company. In case of a transfer by executors, administrators, guardians or other legal representatives,
duly authenticated evidence of their authority shall be produced and may be required to be deposited and remain with the Company
in its discretion.

 

(b)         Each
Warrant issued in accordance with this Section 2.3 shall bear the restrictive legend set forth on the face of this Warrant,
unless the Holder or transferee thereof supplies to the Company an opinion of counsel, reasonably satisfactory to the Company,
that the restrictions described in such legend are no longer applicable to such Warrant.

 

(c)         The
transfer of Warrants and any Equity Interest purchased thereunder shall be permitted, so long as such transfer is pursuant to a
transaction that complies with, or is exempt from, the provisions of the Securities Act, and the Company may require an opinion
of counsel in form and substance reasonably satisfactory to it to such effect prior to effecting any transfer of Warrants or any
Equity Interest purchased thereunder.

 

ARTICLE III

 

EXERCISE OF WARRANT; EXCHANGE
FOR EQUITY INTEREST

 

SECTION 3.1  Exercise
of Warrants. This Warrant shall not be exercisable unless and until Maker fails to pay Holder the entire unamortized principal
amount of the Note and any accrued and unpaid interest thereon as of the Maturity Date (as defined in the Note) or such earlier
date as is required pursuant to an Acceleration Notice (as defined in the Note) issued by Holder in accordance with the terms thereof.
On any Business Day after this Note first becomes exercisable, but before the Expiration Date, the Holder may exercise this Warrant,
in whole or in part, by delivering to the Company this Warrant accompanied by a properly completed Exercise Form in the form of
Annex 1 and a check in an aggregate amount equal to the applicable Exercise Price.

 

SECTION 3.2  Issuance
of Equity Interest.

 

(a)         The
Company represents and warrants that the authorized Equity Interest of the Company consists solely of (i) 5,000,000,000 shares
of common stock, par value $0.001 per share, of which only 295,704,136 common shares have been issued and remain outstanding as
of the date hereof and (ii) 500,000,000 shares of preferred stock, none of which preferred shares have been issued as of the date
hereof. The shares of common stock of the Company issued and outstanding as of the date hereof are duly authorized, validly issued,
fully paid and non-assessable. The delivery to the Holder of certificates representing the Equity Interest that the Holder purchases
pursuant to the exercise of this Warrant shall grant to the Holder good and valid title to the Equity Interest represented by such
certificate, free and clear of any and all liens, pledges, security interests, charges or encumbrances of any kind or nature or
any option, warrant or trust having the practical effect of any of the foregoing.

 

    	 	5	 

     

    

  

(b)         Immediately
upon the exercise of this Warrant in accordance with Section 3.1, the Company (the "Delivery Date") shall
issue the Equity Interest that the Holder has purchased pursuant to such exercise, deliver to the Holder the certificates representing
such Equity Interest and reflect the issuance of such Equity Interest, which Equity Interest shall be duly authorized, validly
issued, outstanding, fully paid and non-assessable, in the Company’s shareholder records (maintained by the Company or its
duly appointed transfer agent), whereupon the Holder shall be deemed for all purposes, effective as of the Delivery Date, to be
a holder of record and beneficial owner of the Equity Interest that it has purchased pursuant to such exercise.

 

(c)         If
a Holder shall exercise this Warrant for less than all of the Equity Interest which could be purchased or received hereunder, the
Company shall issue to the Holder, within five (5) Business Days of the Delivery Date, a new Warrant of like kind and tenor to
this Warrant evidencing the right to purchase the remaining Equity Interest represented by the Warrant. This Warrant shall be cancelled
upon surrender thereof pursuant to Section 3.1.

 

(d)         The
Company shall pay all Taxes (other than any applicable income or similar Taxes payable by a Holder of a Warrant) attributable to
the initial issuance of any Equity Interest upon the exercise or exchange of this Warrant or any successor Warrant; provided,
however, that the Company shall not be required to pay any Tax which may be payable in respect of any transfer involved
in the issuance of a successor to this Warrant in a name other than that of the Holder of the Warrant being exercised or exchanged.

 

(e)         Except
as set forth in any document that is un-redacted and publicly filed with the U.S. Securities and Exchange Commission, neither the
Company nor its Subsidiaries has any liabilities or obligations of any nature (whether absolute, accrued, contingent or otherwise
and whether due or to become due) which are not fully reflected or reserved against on the balance sheet in accordance with GAAP,
except for liabilities and obligations incurred in the ordinary course of business and consistent with past practice since the
date thereof.

 

SECTION 3.3  Adjustment
of Holder’s Equity Interest and/or Exercise Price. The Equity Interest issuable upon exercise of this Warrant (such Equity
Interest is referred to herein as the "Holder's Equity Interest") shall be subject to adjustment from time to
time in accordance with this Section 3.3.

 

SECTION 3.3.1  Issuance
of Additional Equity Interest; Capital Reorganization or Capital Reclassifications. If, at any time after the date hereof,
the Equity Interests of the Company shall be changed into or exchanged for a different number or kind of shares of stock or other
securities of the Company or of another corporation, whether through reorganization, recapitalization, stock split-up, combination
of shares, merger or consolidation (including, without limitation, any subdivision or combination of Equity Interest), then in
each case the Company shall cause effective provision to be made so that this Warrant shall, effective as of the effective date
of such event retroactive to the record date, if any, of such event, be exercisable or exchangeable for the kind and number of
equity securities, cash or other property to which a holder of the Equity Interest deliverable upon exercise or exchange of this
Warrant would have been entitled upon such event and any such provision shall include adjustments in respect of such securities
or other property that shall be equivalent to the adjustments provided for in this Warrant with respect to such Warrant.

 

    	 	6	 

     

    

  

SECTION 3.3.2  Consolidations
and Mergers; Dissolution.

 

(a)         If,
at any time after the date hereof, the Company shall consolidate with, merge with or into, or sell all or substantially all of
its assets or property to, another Person, then the Company shall cause effective provision to be made so that each Warrant shall,
effective as of the effective date of such event retroactive to the record date, if any, of such event, be exercisable or exchangeable
for the kind and number of shares of stock, membership or other equity interests, other securities, cash or other property to which
a holder of the Equity Interest deliverable upon exercise or exchange of such Warrant would have been entitled upon such event.
The Company shall not consolidate or merge unless, prior to consummation, the successor corporation (if other than the Company)
assumes the obligations of this paragraph by written instrument executed and mailed to the Holder at the Holder’s address
set forth in Section 5.1. A sale or lease of all or substantially all the assets of the Company for a consideration (apart from
the assumption of obligations) consisting primarily of securities is a consolidation or merger for the foregoing purposes.

 

(b)         In
case a voluntary or involuntary dissolution, liquidation, or winding up of the Company (other than in connection with a consolidation
or merger covered by subsection (a) above) is at any time proposed, the Company shall give at least 30 days’ prior written
notice to the Holder. Such notice shall contain: (1) the date on which the transaction is to take place; (2) the record date (which
shall be at least 30 days after the giving of the notice) as of which the Holder will be entitled to receive distributions as a
result of the transaction; (3) a brief description of the transaction; (4) a brief description of the distributions to be made
to the Holder as a result of the transaction and (5) an estimate of the fair value of the distributions. On the date of the transaction,
if it actually occurs, this Warrant and all rights hereunder shall terminate.

 

SECTION 3.3.3  Notice;
Calculations; Etc. Whenever the Equity Interest issuable hereunder shall be adjusted as provided in this Section 3.3,
the Company shall provide to the Holder a statement, signed by an Executive Officer, describing in detail the facts requiring such
adjustment and setting forth a calculation of the Equity Interest applicable to each Warrant after giving effect to such adjustment.
All calculations under this Section 3.3 shall be made to the nearest one hundredth of a cent or to the nearest one-tenth
of a unit, as the case may be.

 

    	 	7	 

     

    

  

ARTICLE IV

 

CERTAIN OTHER RIGHTS

 

SECTION 4.1  Registration
Rights.

 

(a)         At
any time at which this Warrant or the Equity Interest underlying the same remains outstanding, upon the request of the Holder,
the Company will enter into a registration rights agreement with Holder (the "Rights Agreement"). Such Rights
Agreement shall provide that beginning October 1, 2015, if the Company is eligible for the use of a registration statement on Form
S-3, then the Holder shall have the right to request an initial registration and thereafter on a quarterly basis after such initial
registration shall have been declared effective by the U.S. Securities and Exchange Commission, registration of its Equity Interests
on Form S-3 or any similar short-form registration (each, a "Demand Registration"). The Rights Agreement will
provide that each request for a Demand Registration shall specify the approximate number of Equity Interests requested to be registered
and that the Company shall cause a registration statement on Form S-3 (or any successor form) to be filed within twenty (20) days
after the date on which the initial request is given and shall use its reasonable best efforts to cause such Registration Statement
to be declared effective by the Commission as soon as practicable thereafter. The Rights Agreement will provide that the Company
may postpone for up to ninety (90) days the filing or effectiveness of a registration statement for a Demand Registration if the
Company determines in its reasonable good faith judgment that such Demand Registration would (i) materially interfere with a significant
acquisition, corporate reorganization or other similar transaction involving the Company; (ii) require premature disclosure of
material information that the Company has a bona fide business purpose for preserving as confidential; or (iii) render the Company
unable to comply with requirements under the Securities Act or Exchange Act. The Rights Agreement shall contain such other terms
and conditions applicable to the Holder no less favorable to the Holder than registration rights made available to any other holder
of any Equity Interest or other equity security of the Company.

 

(b)         The
rights to cause the Company to register Equity Interests pursuant hereto may be assigned (but only with all related obligations)
by the Holder in a Qualified Assignment; provided, that, (i) the Company is, upon or within a reasonable time after such transfer,
furnished with written notice of the name and address of such transferee and the securities with respect to which such registration
rights are being assigned, (ii) such transferee or assignee agrees in writing to be bound by and subject to the terms and conditions
of this Warrant, (iii) such assignment shall be effective only if immediately following such transfer the further disposition of
such securities by transferee or assignee is restricted under the Securities Act, and (iv) such assignment shall be effective only
if immediately following such transfer such Equity Interests continue to be Equity Interests of the Company.

 

SECTION
4.2 Reservation of Underlying Shares.

 

(a)          The
Company covenants at all times to reserve and keep available out of its
authorized shares of Common Stock, free from preemptive rights, solely for the purpose of issue upon exercise of the Warrant as
herein provided, the maximum number of shares of Common Stock as shall then be issuable upon the exercise of this Warrant. 

 

(b)          The
Company covenants that all shares of Common Stock issued upon exercise of the Warrant which shall be so issuable shall, when issued,
be duly and validly issued and fully paid and non-assessable, free from all taxes, liens and charges with respect to the purchase
and the issuance of the shares, and shall not have any legend or restrictions on resale, except as required by the Rights Agreement
or hereby.

 

    	 	8	 

     

    

  

ARTICLE V

 

MISCELLANEOUS

 

SECTION 5.1  Notices.
Unless otherwise specifically provided herein, any notice or other communication herein required or permitted to be given shall
be in writing and shall be made by electronic mail, personal service, facsimile or reputable courier service:

 

(a)         If
to the Company, to:

 

TWINLAB CONSOLIDATED HOLDINGS, INC.

632 Broadway, Suite 201

New York, NY 10012

Attention: Richard H. Neuwirth, Chief Legal Officer

Facsimile: (212) 260-1853

e-mail: RNeuwirth@twinlab.com

 

with a copy to:

 

WILK AUSLANDER LLP

1515 Broadway

New York, New York 10036

Attention: Joel I. Frank, Esq.

Facsimile: (212) 762-6380

e-mail: jfrank@wilkauslander.com

 

(b)         If
to the Holder, to:

 

Great Harbor Capital, LLC

3133 Orchard Vista Drive SE

Grand Rapids, MI 49546

Attention: Mark J. Bugge, Secretary

Facsimile: (616) 808-2721

e-mail: Mark.Bugge@vaegr.com

 

Unless otherwise specifically provided herein,
any notice or other communication shall be deemed to have been given when delivered in person or by courier service, upon receipt
of electronic mail or upon receipt of facsimile.

 

SECTION 5.2  No
Voting Rights: Limitations of Liability. This Warrant shall not entitle the holder thereof to any voting rights or, except
as otherwise provided or referenced herein, other rights of an equity owner of the Company. No provision hereof, in the absence
of affirmative action by the Holder to purchase its Equity Interest, and no enumeration herein of the rights or privileges of the
Holder shall give rise to any liability of the Holder for the Exercise Price of the Equity Interest acquirable by exercise hereunder
or as a stockholder of the Company.

 

    	 	9	 

     

    

  

SECTION 5.3  Amendments
and Waivers. Any provision of this Warrant may be amended or waived, but only pursuant to a written agreement signed by the
Company and the Holder.

 

SECTION 5.4  Severability.
If any provision of this Warrant shall be held to be invalid or unenforceable, such invalidity or unenforceability shall attach
only to such provision and shall not in any way affect or render invalid or unenforceable any other provision of this Agreement,
and such provision shall be deemed to be restated to reflect the parties' original intentions as nearly as possible in accordance
with Applicable Law(s).

 

SECTION 5.5  Specific
Performance. The Holder shall have the right to specific performance by the Company of the provisions of this Warrant, in addition
to any other remedies it may have at law or in equity. The Company hereby irrevocably waives, to the extent that it may do so under
Applicable Law, any defense based on the adequacy of a remedy at law which may be asserted as a bar to the remedy of specific performance
in any action brought against the Company for specific performance of this Warrant by the Holder.

 

SECTION 5.6  Binding
Effect. This Warrant shall be binding upon and inure to the benefit of the Company, the Holder and their respective successors
and assigns.

 

SECTION 5.7  Counterparts.
This Warrant may be executed in several counterparts, and/or by the execution of counterpart signature pages that may be attached
to one or more counterparts of this Warrant, and all so executed shall constitute one agreement binding on all of the parties hereto,
notwithstanding that all of the parties hereto are not signatory to the original or the same counterpart. In addition, any counterpart
signature page may be executed by any party wherever such party is located, and may be delivered by telephone facsimile or by electronic
mail in PDF format, and any such transmitted signature pages may be attached to one or more counterparts of this Warrant, and such
faxed or sent by electronic mail signature(s) shall have the same force and effect, and be as binding, as if original signatures
had been executed and delivered in person.

 

SECTION 5.8  Entire
Agreement. This Warrant and the Note, together with the other documents and instruments entered into by the parties thereto
in connection therewith, constitute the entire understanding among the parties hereto with respect to the subject matter hereof
and supersedes any prior agreements, written or oral, with respectto the subject matter hereof.

 

SECTION 5.9  Governing
law. THIS WARRANT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW YORK, WITHOUT REFERENCE TO ITS CONFLICT
OF LAWS RULES AND PRINCIPLES. THE PARTIES HEREBY EXPRESSLY AND IRREVOCABLY SUBMIT TO THE JURISDICTION OF THE STATE AND FEDERAL
COURTS LOCATED IN NEW YORK COUNTY, NEW YORK FOR THE PURPOSE OF ANY LITIGATION BASED HEREON, OR ARISING OUT OF, UNDER, OR IN CONNECTION
WITH, THIS WARRANT, AND IRREVOCABLY AGREE TO BE BOUND BY ANY JUDGMENT RENDERED THEREBY IN CONNECTION WITH SUCH LITIGATION. THE
PARTIES HEREBY EXPRESSLY AND IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY OBJECTION WHICH THEY MAY HAVE OR HEREAFTER
MAY HAVE TO THE LAYING OF VENUE OF ANY SUCH LITIGATION BROUGHT IN ANY SUCH COURT REFERRED TO ABOVE AND ANY CLAIM THAT ANY SUCH
LITIGATION HAS BEEN BROUGHT IN AN INCONVENIENT FORUM. TO THE EXTENT THAT ANY PARTY HAS OR HEREAFTER MAY ACQUIRE ANY IMMUNITY FROM
JURISDICTION OF ANY COURT OR FROM ANY LEGAL PROCESS (WHETHER THROUGH SERVICE OR NOTICE, ATTACHMENT PRIOR TO JUDGMENT, ATTACHMENT
IN AID OF EXECUTION OR OTHERWISE) WITH RESPECT TO ITSELF OR ITS PROPERTY, THE PARTY HEREBY IRREVOCABLY WAIVES SUCH IMMUNITY IN
RESPECT OF ITS OBLIGATIONS UNDER THIS WARRANT.

 

    	 	10	 

     

    

  

SECTION 5.10  Expenses.
The Company will promptly (and in any event within thirty (30) days of receiving any statement or invoice therefor) pay all reasonable
fees, expenses and costs relating hereto, including, but not limited to, (i) the cost of reproducing this Warrant, (ii) the fees
and disbursements of counsel to the Holder in preparing this Warrant, (iii) all transfer, stamp, documentary or other similar
Taxes, assessments or charges levied by any governmental or revenue authority in respect hereof or any other document referred
to herein, (iv) fees and expenses (including, without limitation, reasonable attorneys' fees) incurred in respect of the enforcement
by the Holder of the rights granted to the Holder under this Warrant, and (v) the expenses relating to the consideration, negotiation,
preparation or execution of any amendments, waivers or consents requested by the Company pursuant to the provisions hereof, whether
or not any such amendments, waivers or consents are executed.

 

SECTION 5.11  Attorneys'
Fees. In any action or proceeding brought by a party to enforce any provision of this Warrant, the prevailing party shall be
entitled to recover the reasonable costs and expenses incurred by it or him in connection therewith (including reasonable attorneys’
and paralegals’ fees and costs incurred before and at any trial or arbitration and at all appellate levels), as well as all
other relief granted or awarded in such action or other proceeding.

 

SECTION 5.12  Filings.
The Company shall, at its own expense, promptly execute and deliver, or cause to be executed and delivered, to the Holder all applications,
certificates, instruments and all other documents and papers that the Holder may reasonably request in connection with the obtaining
of any consent, approval, qualification, or authorization of any Federal, provincial, state or local government (or any agency
or commission thereof) necessary or appropriate in connection with, or for the effective exercise of, the Warrant (and/or any successor
Warrant(s) hereto).

 

SECTION 5.13  Other
Transactions. Nothing contained herein shall preclude the Holder from engaging in any transaction, in addition to those contemplated
by this Warrant with the Company or any of its Affiliates in which the Company or such Affiliate is not restricted hereby from
engaging with any other Person.

 

    	 	11	 

     

    

  

SECTION 5.14  Waiver
of Jury Trial. THE HOLDER AND THE COMPANY HEREBY KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVE ANY RIGHTS THEY MAY HAVE
TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION BASED HEREON, OR ARISING OUT OF, UNDER, OR IN CONNECTION WITH, THIS WARRANT, OR
ANY COURSE OF CONDUCT, COURSE OF DEALING, STATEMENTS (WHETHER VERBAL OR WRITTEN) OR ACTIONS OF THE HOLDER OR THE COMPANY. THE COMPANY
ACKNOWLEDGES AND AGREES THAT IT HAS RECEIVED FULL AND SUFFICIENT CONSIDERATION FOR THIS PROVISION AND THAT THIS PROVISION IS A
MATERIAL INDUCEMENT FOR THE HOLDER ENTERING INTO THIS WARRANT.

 

SECTION 5.15  Headings.
Section titles and captions contained in this Warrant are inserted only as a matter of convenience and for reference. The titles
and captions in no way define, limit, extend or describe the scope of this Warrant or the intent of any provision hereof.

 

SECTION 5.16  No
Third-Party Beneficiaries. This Warrant is for the sole benefit of the Company and the Holder and their respective successors
and, in the case of the Holder, permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any
other Person any legal or equitable right, benefit or remedy of any nature whatsoever, under or by reason of this Warrant.

 

[Remainder of page intentionally left blank;
signatures on following page]

 

    	 	12	 

     

    

  

IN WITNESS WHEREOF, the undersigned
has caused this Warrant to be duly executed and delivered by an authorized officer, all as of the date and year first above written.

 

	 	TWINLAB CONSOLIDATED HOLDINGS, INC., a Nevada corporation
	 	 	 
	 	By:	/s/ Thomas A. Tolworthy
	 	Name:  Thomas A. Tolworthy
	 	Title:    Chief Executive Officer and President

 

Signature Page To Warrant 2016 - 2

 

    	 	13	 

     

    

  

	ACKNOWLEDGED AND AGREED:	 
	 	 
	Great Harbor Capital, LLC	 
	 	 	 
	By:	/s/ Mark J. Bugge	 
	Name: Mark J. Bugge	 
	Title: Secretary	 

 

Signature Page To Warrant 2016 -
2

 

    	 	14	 

     

    

 

ANNEX 1

 

ELECTION TO EXERCISE FORM

 

(To Be Executed By the Holder of This Warrant

 

In Order to Exercise This Warrant)

 

The undersigned hereby
irrevocably elects to exercise the right covered by this Warrant to purchase ____________________ of the Equity Interest of TWINLAB
CONSOLIDATED HOLDINGS, INC., a Nevada corporation, according to the conditions hereof
and herewith makes payment in full of the Exercise Price with respect to such Equity Interest.

 

	 	 	 
	 	Signature	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	Address	 

 

	Dated:	 	 

 

    	 	 	 

     

    

 

ANNEX 2

 

ASSIGNMENT FORM

 

(To Be Executed By the Holder of This Warrant

 

In Order to Assign This Warrant)

 

FOR VALUE RECEIVED, the
undersigned hereby sells, assigns and transfers unto _____________________________ this Warrant and all rights evidenced thereby
and does irrevocably constitute and appoint ___________________, attorney, to transfer the said Warrant on the books of TWINLAB
CONSOLIDATED HOLDINGS, INC., a Nevada corporation.

 

	 	 	 
	 	Signature	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	Address	 

 

	Dated:	 	 

 

    	 	 	 

     

    

 

ANNEX 3

 

EXCHANGE FORM

 

(To Be Executed By the Holder of This Warrant

 

In Order to Exchange and Assign This Warrant)

 

The undersigned hereby
irrevocably elects to exchange this Warrant to purchase ________________, of the Equity Interest of
TWINLAB CONSOLIDATED HOLDINGS, INC., a Nevada corporation, for ___________
Warrants to purchase the Equity Interest of TWINLAB CONSOLIDATED HOLDINGS, INC., a
Nevada corporation, set forth below to the Persons named and hereby sells, assigns and transfers unto such Persons that portion
of this Warrant represented by such new Warrants and all rights evidenced thereby and does irrevocably constitute and appoint ____________________,
attorney, to exchange and transfer this Warrant as aforesaid on the books of TWINLAB CONSOLIDATED HOLDINGS, INC.,
a Nevada corporation.

 

	Equity Interest	 	Assignee	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	Signature	 

 

	 	 	 
	 	 	 
	 	Address	 

 

FOR USE BY THE COMPANY ONLY:

 

This Warrant No. __ cancelled (or transferred
or exchanged) this ________ day of _____________, ____________ of the Equity Interest of
TWINLAB CONSOLIDATED HOLDINGS, INC., a Nevada corporation, issued therefor
in the name of ____ ___________ Warrant No. ___ for ________, of the Equity Interest of
TWINLAB CONSOLIDATED HOLDINGS, INC., a Nevada corporation, in the name of
_________________________.

 

	Dated:Exhibit  10.116

 

AMENDMENT NO. 8 TO CREDIT AND SECURITY
AGREEMENT

 

THIS
AMENDMENT NO. 8 TO CREDIT AND SECURITY AGREEMENT (this “Amendment”) is made as of this 28th day
of January, 2016, by and among TWINLAB CONSOLIDATED HOLDINGS, INC., a Nevada corporation (“TCHI”), TWINLAB
CONSOLIDATION CORPORATION, a Delaware corporation (“TCC”), TWINLAB HOLDINGS, INC., a Michigan corporation,
ISI BRANDS INC., a Michigan corporation, TWINLAB CORPORATION, a Delaware corporation (“Twinlab Corporation”),
NUTRASCIENCE LABS, INC., a Delaware corporation (formerly known as TCC CM Subco I, Inc.), and NUTRASCIENCE LABS IP CORPORATION,
a Delaware corporation (formerly known as TCC CM Subco II, Inc.), ORGANIC HOLDINGS LLC, a Delaware limited liability company,
RESERVE LIFE ORGANICS, LLC, a Delaware limited liability company, RESVITALE, LLC, a Delaware limited liability company,
RE-BODY, LLC, a Delaware limited liability company, INNOVITAMIN ORGANICS, LLC, a Delaware limited liability company,
ORGANICS MANAGEMENT LLC, a Delaware limited liability company, COCOAWELL, LLC, a Delaware limited liability company,
FEMBODY, LLC, a Delaware limited liability company, RESERVE LIFE NUTRITION, L.L.C., a Delaware limited liability
company, INNOVITA SPECIALTY DISTRIBUTION, LLC, a Delaware limited liability company, and JOIE ESSANCE, LLC, a Delaware
limited liability company (each of the foregoing Persons being
referred to herein individually as a “Borrower”, and collectively as “Borrowers”), and MIDCAP
FUNDING X TRUST, a Delaware statutory trust, as successor-by-assignment from MidCap Financial Trust (as Agent for Lenders,
“Agent”, and individually, as a Lender), and the other financial institutions or other entities from time to
time parties to the Credit Agreement referenced below, each as a Lender.

 

RECITALS

 

A.           Pursuant
to that certain Credit and Security Agreement dated as of January 22, 2015 by and among Borrowers, Agent and Lenders (as amended
by that certain Amendment No. 1 to Credit and Security Agreement and Limited Consent dated as of February 4, 2015, by that certain
Amendment No. 2 to Credit and Security Agreement and Limited Consent dated as of April 7, 2015, by that certain Amendment No. 3
to Credit and Security Agreement and Limited Consent dated as of April 30, 2015, by that certain Amendment No. 4 to Credit and
Security Agreement and Limited Waiver dated as of June 30, 2015, by that certain Amendment No. 5 to Credit and Security Agreement
and Limited Consent dated as of June 30, 2015, by that certain Amendment No. 6 to Credit and Security Agreement, Limited Consent
and Limited Waiver dated as of September 9, 2015, by that certain Amendment No. 7 and Joinder Agreement to Credit and Security
Agreement dated as of October 5, 2015 and as further amended hereby and as it may be further amended, modified and restated from
time to time, the “Credit Agreement”), Agent and Lenders agreed to make available to Borrowers a secured revolving
credit facility in a principal amount of up to $15,000,000 from time to time (as amended, modified, supplemented, extended and
restated from time to time, collectively, the “Loans”). Capitalized terms used but not otherwise defined in
this Amendment shall have the meanings set forth in the Credit Agreement.

 

    	 	 	 

     

    

 

AGREEMENT

 

NOW, THEREFORE,
in consideration of the foregoing, the terms and conditions set forth in this Amendment, and other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, Agent, Lenders and Borrowers hereby agree as follows:

 

1.           Recitals.
 This Amendment shall constitute a Financing Document and the Recitals set forth above shall be construed as part of this Amendment
as if set forth fully in the body of this Amendment.

 

2.           Amendment
to Credit Agreement. 

 

(a)          Section
1.1 of the Credit Agreement is hereby amended to add the defined terms “Golisano Holdings,” “Golisano Holdings
Debt,” “Subordination Agreement (Golisano Holdings),” “Great Harbor,” “Great Harbor Debt”
and “Subordination Agreement (Great Harbor),” in their respective alphabetical order:

 

“Golisano Holdings”
means Golisano Holdings LLC, a New York limited liability company.

 

“Golisano Holdings Debt”
means the “Subordinated Loans” (as that term is defined in the Subordination Agreement (Golisano Holdings). 

 

“Great Harbor” means
Great Harbor Capital, LLC, a Delaware limited liability company.

 

“Great Harbor Debt”
means the “Subordinated Loans” (as that term is defined in the Subordination Agreement (Great Harbor). 

 

“Subordination Agreement
(Golisano Holdings)” means the Subordination Agreement dated as of January 28, 2016 between Agent and Golisano Holdings and
acknowledged by Borrowers, as the same may be amended, restated, amended and restated, supplemented or otherwise modified from
time to time.

 

“Subordination Agreement
(Great Harbor)” means the Subordination Agreement dated as of January 28, 2016 between Agent and Great Harbor and acknowledged
by Borrowers, as the same may be amended, restated, amended and restated, supplemented or otherwise modified from time to time.

 

(b)          Section
1.1 – Definitions of Commitment Expiry Date and Permitted Debt. The defined terms “Commitment Expiry Date”
and “Permitted Debt” in Section 1.1 of the Credit Agreement are hereby amended and restated, respectively, in their
entirety as follows:

 

“Commitment Expiry Date”
means the date that is four (4) years following the Closing Date.

 

    	 	 	 

     

    

 

“Permitted Debt” means:
(a) Borrowers’ and its Subsidiaries’ Debt to Agent and each Lender under this Agreement and the other Financing
Documents; (b) Debt incurred as a result of endorsing negotiable instruments received in the Ordinary Course of Business;
(c) purchase money Debt with respect to equipment, Debt listed on Schedule 5.1, and such other Debt (other than the Essex
Lease) not to exceed $3,000,000 at any time (whether in the form of a loan or a Capital Lease) used solely to acquire equipment
used in the Ordinary Course of Business and secured only by such equipment; (d) Debt existing on the date of this Agreement
and described on Schedule 5.1 and any Refinancing Debt with respect thereto; (e) Debt in the form of insurance premiums
financed through the applicable insurance company; (f) trade accounts payable arising and paid on a timely basis and in the
Ordinary Course of Business; (g) Subordinated Debt (for the avoidance of doubt, including the Golisano Holdings Debt and Great
Harbor Debt), (h) the Essex Lease; (i) the Nutricap Seller Notes; (j) the JL Properties Reimbursement Agreement; and (k) the DVA
Note, to the extent issued in accordance with the terms of the DVA Put Agreement.

 

3.           Confirmation
of Representations and Warranties; Reaffirmation of Security Interest.  Each Borrower hereby (a) confirms that all of the
representations and warranties set forth in the Credit Agreement are true and correct with respect to such Borrower as of the date
hereof, and (b) covenants to perform its respective obligations under the Credit Agreement. Each Borrower confirms and agrees
that all security interests and Liens granted to Agent continue in full force and effect, and all Collateral remains free and clear
of any Liens, other than those granted to Agent and Permitted Liens. Nothing herein is intended to impair or limit the validity,
priority or extent of Agent’s security interests in and Liens on the Collateral. 

 

4.           Enforceability.
 This Amendment constitutes the legal, valid and binding obligation of each Borrower, and is enforceable against each Borrowers
in accordance with its terms, except as the enforceability thereof may be limited by bankruptcy, insolvency or other similar laws
relating to the enforcement of creditors’ rights generally and by general equitable principles.

 

5.           Costs
and Fees. Borrowers shall be responsible for the payment of all reasonable costs and fees of Agent’s counsel incurred
in connection with the preparation of this Amendment and any related documents. If Agent or any Lender uses in-house counsel for
any of these purposes, Borrowers further agree that the Obligations include reasonable charges for such work commensurate with
the fees that would otherwise be charged by outside legal counsel selected by Agent or such Lender for the work performed. Borrowers
hereby authorize Agent to deduct all of such fees set forth in this Section 8 from the proceeds of one or more Revolving Loans
made under the Credit Agreement.

 

6.           Conditions
to Effectiveness. This Amendment shall become effective as of the date on which each of the following conditions has been
satisfied (the “Effective Date”):

 

    	 	 	 

     

    

 

(a)          Borrowers
shall have delivered to Agent this Amendment, duly executed by an authorized officer of each Borrower;

 

(b)          Agent
shall have received the fully executed copies of the Subordination Agreement (Great Harbor), the Subordination Agreement (Golisano
Holdings), the Subordinated Debt Documents, the Subordinated Loan Documents (as such term is defined in the Subordination Agreement
(Great Harbor)) and the Subordinated Loan Documents (as such term is defined in the Subordination Agreement (Golisano Holdings)),
in each case in form and substance satisfactory to Agent;

 

(c)          all
representations and warranties of Borrowers contained herein shall be true and correct in all material respects as of the Effective
Date (and such parties’ delivery of their respective signatures hereto shall be deemed to be its certification thereof);
and

 

(d)          Agent
shall have received from Borrowers of all of the fees owing pursuant to this Amendment and Agent’s reasonable out-of-pocket
legal fees and expenses.

 

7.           Release.
Each Borrower, voluntarily, knowingly, unconditionally and irrevocably, with specific and express intent, for and on behalf of
itself and all of its respective parents, subsidiaries, affiliates, members, managers, predecessors, successors, and assigns, and
each of their respective current and former directors, officers, shareholders, agents, and employees (collectively, “Releasing
Parties”), does hereby fully and completely release, acquit and forever discharge each Indemnitee of and from any and
all actions, causes of action, suits, debts, disputes, damages, claims, obligations, liabilities, costs, expenses and demands of
any kind whatsoever, at law or in equity, whether matured or unmatured, liquidated or unliquidated, vested or contingent, choate
or inchoate, known or unknown that the Releasing Parties (or any of them) has against the Indemnitees (or any of them) that directly
or indirectly arise out of, are based upon or are in any manner connected with any Prior Related Event. “Prior Related
Event” means any transaction, event, circumstance, action, failure to act, occurrence of any type or sort, whether known
or unknown, which occurred, existed, was taken, was permitted or begun in accordance with, pursuant to or by virtue of (a) any
of the terms of this Amendment or any other Financing Document, (b) any actions, transactions, matters or circumstances related
hereto or thereto, (c) the conduct of the relationship between any Indemnitee and any Borrower, or (d) any other actions
or inactions by any Indemnitee, all on or prior to the Effective Date. Each Borrower acknowledges that the foregoing release is
a material inducement to Agent’s and Lender’s decision to enter into this Amendment and to agree to the modifications
contemplated hereunder.

 

8.           No
Waiver or Novation. The execution, delivery and effectiveness of this Amendment shall not, except as expressly provided
in this Amendment, operate as a waiver of any right, power or remedy of Agent, nor constitute a waiver of any provision of the
Credit Agreement, the Financing Documents or any other documents, instruments and agreements executed or delivered in connection
with any of the foregoing. Except as expressly provided herein, nothing herein is intended or shall be construed as a waiver of
any existing Defaults or Events of Default under the Credit Agreement or other Financing Documents or any of Agent’s rights
and remedies in respect of such Defaults or Events of Default. This Amendment (together with any other document executed in connection
herewith) is not intended to be, nor shall it be construed as, a novation of the Credit Agreement.

 

    	 	 	 

     

    

 

9.           Affirmation.
Except as specifically amended and waived pursuant to the terms hereof, the Credit Agreement and all other Financing Documents
(and all covenants, terms, conditions and agreements therein) shall remain in full force and effect, and are hereby ratified and
confirmed in all respects by Borrowers. Each Borrower covenants and agrees to comply with all of the terms, covenants and conditions
of the Credit Agreement (as amended hereby) and the Financing Documents, notwithstanding any prior course of conduct, waivers,
releases or other actions or inactions on Agent’s or any Lender’s part which might otherwise constitute or be construed
as a waiver of or amendment to such terms, covenants and conditions.

 

10.         Miscellaneous.

 

(a)          Reference
to the Effect on the Credit Agreement.  Upon the effectiveness of this Amendment, each reference in the Credit Agreement
to “this Agreement,” “hereunder,” “hereof,” “herein,” or words of similar import
shall mean and be a reference to the Credit Agreement, as amended by this Amendment. Except as specifically amended and waived
above, the Credit Agreement, and all other Financing Documents (and all covenants, terms, conditions and agreements therein), shall
remain in full force and effect, and are hereby ratified and confirmed in all respects by Borrowers.

 

(b)          Incorporation
of Credit Agreement Provisions. The provisions contained in Section 11.6 (Indemnification), Section 12.8 (Governing Law; Submission
to Jurisdiction) and Section 12.9 (Waiver of Jury Trial) of the Credit Agreement are incorporated herein by reference to the same
extent as if reproduced herein in their entirety.

 

(c)          Headings.
Section headings in this Amendment are included for convenience of reference only and shall not constitute a part of this Amendment
for any other purpose.

 

(d)          Counterparts.
This Amendment may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the
signatures thereto and hereto were upon the same instrument. Signatures by facsimile or by electronic mail delivery of an electronic
version (e.g., .pdf or .tif file) of an executed signature page shall be treated as delivery of an original and shall bind
the parties hereto. This Amendment constitutes the entire agreement and understanding among the parties hereto and supersede any
and all prior agreements and understandings, oral or written, relating to the subject matter hereof.

 

[SIGNATURES APPEAR ON FOLLOWING PAGES]

 

    	 	 	 

     

    

 

(Signature Page to Amendment No. 8 to
Credit and Security Agreement)

 

IN WITNESS WHEREOF,
intending to be legally bound, and intending that this document constitute an agreement executed under seal, the undersigned have
executed this Amendment under seal as of the day and year first hereinabove set forth.

 

	AGENT:	MIDCAP FUNDING X TRUST, a Delaware statutory trust, as successor-by-assignment from MidCap Financial Trust
	 	 	 
	 	By:	Apollo Capital Management, L.P.,
	 	 	its investment manager
	 	 	 
	 	By:	Apollo Capital Management GP, LLC,
	 	its general partner

 

	 	By:	/s/
    Maurice     Amsellem	(SEAL)

	 	Name:	Maurice Amsellem	 
	 	Title:	Authorized Signatory	 

 

	LENDER:	MIDCAP FUNDING X TRUST, a Delaware statutory trust, as successor-by-assignment from MidCap Financial Trust
	 	 	 
	 	By:	Apollo Capital Management, L.P.,
	 	 	its investment manager
	 	 	 
	 	By:	Apollo Capital Management GP, LLC,
	 	its general partner

 

	 	By:	/s/
    Maurice     Amsellem	(SEAL)

	 	Name:	Maurice Amsellem	 
	 	Title:	Authorized Signatory	 

 

    	 	 	 

     

    

 

(Signature Page to Amendment No. 8 to
Credit and Security Agreement)

 

	BORROWERS:	 	TWINLAB
    CONSOLIDATION CORPORATION
	 	 	 
	 	 	 	By:	 /s/ Thomas A. Tolworthy	(Seal)
	 	 	 	Name:
    Thomas A. Tolworthy
	 	 	 	Title:   Chief
    Executive Officer and President
	 	 	 	 	 	 
	TWINLAB
    CONSOLIDATED HOLDINGS, INC.	 	TWINLAB
    HOLDINGS, INC.	 
	 	 	 	 	 	 
	By:	/s/
    Thomas A. Tolworthy	(Seal)	By:	/s/
    Thomas A. Tolworthy	(Seal)
	Name:  Thomas
    A. Tolworthy	Name:  Thomas
    A. Tolworthy
	Title:  Chief
    Executive Officer and President	Title:  Chief
    Executive Officer and President
	 	 	 	 	 	 
	TWINLAB
    CORPORATION	 	ISI
    BRANDS INC.	 
	 	 	 	 	 	 
	By:	/s/
    Thomas A. Tolworthy	(Seal)	By:	/s/
    Thomas A. Tolworthy	(Seal)
	Name:  Thomas
    A. Tolworthy	Name:  Thomas
    A. Tolworthy
	Title:  Chief
    Executive Officer and President	Title:  Chief
    Executive Officer and President
	 	 	 	 	 	 
	NUTRASCIENCE
    LABS, INC.	 	NUTRASCIENCE
    LABS IP CORPORATION
	 	 	 	 	 	 
	By:	/s/
    Thomas A. Tolworthy	(Seal)	By:	/s/
    Thomas A. Tolworthy	(Seal)
	Name:  Thomas
    A. Tolworthy	Name:  Thomas
    A. Tolworthy
	Title:  Chief
    Executive Officer and President	Title:  Chief
    Executive Officer and President
	 	 	 	 	 	 
	ORGANIC
    HOLDINGS LLC	 	RESERVE
    LIFE ORGANICS, LLC	 
	 	 	 	 	 	 
	By:	/s/
    Thomas A. Tolworthy	(Seal)	By
    ORGANIC HOLDINGS LLC,	 
	Name:
    Thomas A. Tolworthy	its
    sole Member	 
	Title:  Sole
    Manager	 	 	 
	 	 	 	By:	/s/
    Thomas A. Tolworthy	(Seal)
	 	 	 	Name:
    Thomas A. Tolworthy
	 	 	 	Title:  Sole
    Manager

 

    	 	 	 

     

    

 

(Signature Page to Amendment No. 8 to
Credit and Security Agreement)

 

	RESVITALE,
    LLC	 	RE-BODY,
    LLC	 
	 	 	 	 	 	 
	By
    ORGANIC HOLDINGS LLC,	 	By
    ORGANIC HOLDINGS LLC,	 
	its
    sole Member	 	its
    sole Member	 
	 	 	 	 	 	 
	By:	/s/
    Thomas A. Tolworthy	(Seal)	By:	/s/
    Thomas A. Tolworthy	(Seal)
	Name:
    Thomas A. Tolworthy	Name:
    Thomas A. Tolworthy
	Title:  Sole
    Manager	Title:  Sole
    Manager
	 	 	 	 	 	 
	INNOVITAMIN
    ORGANICS, LLC	 	ORGANICS
    MANAGEMENT LLC	 
	 	 	 	 	 	 
	By
    ORGANIC HOLDINGS LLC,	 	By
    ORGANIC HOLDINGS LLC,	 
	its
    sole Member	 	its
    sole Member	 
	 	 	 	 	 	 
	By:	/s/
    Thomas A. Tolworthy	(Seal)	By:	/s/
    Thomas A. Tolworthy	(Seal)
	Name:
    Thomas A. Tolworthy	Name:
    Thomas A. Tolworthy
	Title:  Sole
    Manager	Title:  Sole
    Manager
	 	 	 	 	 	 
	COCOAWELL,
    LLC	 	FEMBODY,
    LLC	 
	 	 	 	 	 	 
	By
    ORGANIC HOLDINGS LLC,	 	By
    ORGANIC HOLDINGS LLC,	 
	its
    sole Member	 	its
    sole Member	 
	 	 	 	 	 	 
	By:	/s/
    Thomas A. Tolworthy	(Seal)	By:	/s/
    Thomas A. Tolworthy	(Seal)
	Name:
    Thomas A. Tolworthy	Name:
    Thomas A. Tolworthy
	Title:  Sole
    Manager	Title:  Sole
    Manager
	 	 	 	 	 	 
	RESERVE
    LIFE NUTRITION, L.L.C.	 	INNOVITA
    SPECIALTY DISTRIBUTION, LLC	 
	 	 	 	 	 	 
	By
    ORGANIC HOLDINGS LLC,	 	By
    ORGANIC HOLDINGS LLC,	 
	its
    sole Member	 	its
    sole Member	 
	 	 	 	 	 	 
	By:	/s/
    Thomas A. Tolworthy	(Seal)	By:	/s/
    Thomas A. Tolworthy	(Seal)
	Name:
    Thomas A. Tolworthy	Name:
    Thomas A. Tolworthy
	Title:  Sole
    Manager	Title:  Sole
    Manager
	 	 	 	 	 	 
	JOIE
    ESSANCE, LLC	 	 	 	 
	 	 	 	 	 	 
	By
    ORGANIC HOLDINGS LLC,	 	 	 	 
	its
    sole Member	 	 	 	 
	 	 	 	 	 	 
	By:	/s/
    Thomas A. Tolworthy	(Seal)	 	 	 
	Name:
    Thomas A. Tolworthy	 	 	 
	Title:  Sole
    Manager

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}]]